Baroness Meacher

Baroness Meacher

Full title

The Baroness Meacher

Name

Molly Meacher

Party/group

Crossbench

Joined the Lords

16 June 2006

Contact details

House of Lords, London, SW1A 0PW
Tel: 0207 219 4081
meachermc@parliament.uk

Biography

Professional life

Job title Organisation Date
Chairman East London NHS Foundation Trust 2004-

Public life

Post Organisation Date
Chairman Security Industry Authority 2002-04
Deputy Chairman Police Complaints Authority 1999-02
Director Tower Hamlets Healthcare Trust 1994-98
Adviser to Russian Government Department for Overseas Development 1991-94
Mental Health Act Commissioner Mental Health Act Commission 1987-92

Member's focus

Policy
Employment and training
Health services and medicine
Social security and pensions
Social services.
World
Russian Federation
Palestine.

Register of Interests

  • 5: Land and property

    • Two flats in Highgate, London N6, from which rental income is received
  • 7: Overseas visits

    • Visit to Brussels and Tallin, Estonia, 7-8 November 2012 as Chair of the APPG on Drug Policy Reform to attend meeting with EC representatives, MEPs and national members of the Horizontal Group on Drugs, in Brussels, followed by a meeting in Tallin, Estonia with government ministers responsible for drug policy; cost of travel and accommodation met by Open Society Fund via International Drug Policy Commission
    • Visit to Warsaw, 14 and 15 February 2013, to attend a drug policy dialogue; travel costs met by the Open Society Fund via International Drug Policy Commission
    • Visit to Oslo, 6-7 May 2013, as chair of the APPG on Drug Policy Reform; cost of travel and subsistence met by Open Society Fund via International Drug Policy Commission
    • Visit to Belgrade, 21-23 May 2013, as chair of APPG on Drug Policy Reform; cost of travel and subsistence met by Open Society Fund via International Drug Policy Commission
    • Visit to Paris, 18-19 June 2013, as chair of the APPG on Drug Policy Reform; cost of travel and subsistence met by Open Society Fund via International Drug Policy Commission

View all Hansard contributions by this Peer